Three Days at Wounds Australia: Taking DP-Tx Beyond the Product

After three full days exhibiting at the Wounds Australia Conference in Adelaide, I came away reminded of just how diverse the potential applications for DP-Tx™ may be.

ChezLeon was fortunate to attend as the recipient of the inaugural Wounds Australia Incubator Grant, giving us the opportunity to introduce our Differential Pressure Technology to a broad audience of clinicians and healthcare professionals involved in wound care, recovery and rehabilitation.

But we weren't there simply to showcase a product.

We went to start conversations about what may be possible.

Showing the diversity of DP-Tx

DP-Tx was originally developed from my own experience with lymphoedema, but as the technology has evolved, so too has our understanding of where supporting fluid movement may have a role.

At the conference, we were able to demonstrate DP-Tx across very different clinical applications and share real-world case studies, including a significant lower-limb trauma case and our head and neck application.

These cases helped us show something that can sometimes be difficult to explain in words: DP-Tx is a platform technology that can be incorporated into different wearable formats and positioned according to the area of the body requiring support.

It is non-compressive, requires no power and uses normal body movement to create a passive massage effect designed to support fluid movement.

That simplicity is an important part of what makes the technology so versatile.

From real-world outcomes to clinical validation

One of our key reasons for attending Wounds Australia was to connect with clinicians and researchers who may be interested in helping us take the next step.

We have seen encouraging outcomes through patient use and individual case experiences. Now we want to continue building the clinical evidence around those observations through structured evaluation and research.

Finding clinicians who recognise the potential of the technology — and ultimately respected clinical Key Opinion Leaders who can independently evaluate and help guide its development — is an important part of that journey.

Wounds Australia gave us the opportunity to put DP-Tx in front of people working across many different areas of healthcare and ask a simple question:

Where could this technology make a difference?

Now we wait — and keep moving forward

Over the three days, we had many conversations, demonstrated the technology repeatedly and saw a large number of our brochures and business cards leave the stand.

Will every conversation lead somewhere? Of course not.

But I've learnt that the value of a conference isn't always known when you pack up the stand.

Someone may take our brochure back to a colleague. A clinician may remember one of our case studies when they encounter a patient facing a similar challenge. A researcher may see an opportunity that wasn't immediately apparent at the conference.

And sometimes, it may simply be that DP-Tx made enough of an impression to stay somewhere in the back of someone's mind, until the timing is right for it to resurface.

That's the nature of innovation. You don't always know which conversation will matter or when.

So, for now, we keep moving forward, continue building the evidence and partnerships around DP-Tx, and see where those conversations lead.

Three long days at Wounds Australia and another important step in taking DP-Tx from an idea born from one patient's experience towards a technology that may help many more.

If you are a clinician, researcher or healthcare organisation interested in evaluating DP-Tx or exploring its potential within your area of practice, we would love to hear from you.